Trial NCT05171062

View at ClinicalTrials.gov 
Org. Study IDs: CTMS# 21-0153
Secondary IDs: 20210791HU

Last trial update was posted on 2023-07-20

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

No participants were enrolled, the study was inactivated with the IRB on May 15, 2023. The sponsor notified the PI that a Phase II trial had been allowed to proceed by the FDA.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID